Kissei Pharmaceutical Co Ltd 4547
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥3,655.00
- Day Range
- ¥3,640.00–3,735.00
- 52-Week Range
- ¥2,907.00–3,735.00
- Bid/Ask
- ¥3,695.00 / ¥3,725.00
- Market Cap
- ¥163.56 Bil
- Volume/Avg
- 81,900 / 70,456
Key Statistics
- Price/Earnings (Normalized)
- 34.34
- Price/Sales
- 2.15
- Dividend Yield (Trailing)
- 2.35%
- Dividend Yield (Forward)
- 2.46%
- Total Yield
- 6.07%
Company Profile
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company’s operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,981
- Website
- http://www.kissei.co.jp
Comparables
Valuation
|
Metric
|
4547
|
4506
|
4577
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.34 | — | 11.89 |
Price/Book Value | 0.73 | 1.65 | 0.67 |
Price/Sales | 2.15 | 0.78 | 0.77 |
Price/Cash Flow | 22.08 | — | 5.75 |
Price/Earnings
4547
4506
4577
Financial Strength
|
Metric
|
4547
|
4506
|
4577
|
|---|---|---|---|
Quick Ratio | 4.22 | 0.26 | 0.80 |
Current Ratio | 5.92 | 0.52 | 2.24 |
Interest Coverage | 802.56 | −82.97 | 103.88 |
Quick Ratio
4547
4506
4577
Profitability
|
Metric
|
4547
|
4506
|
4577
|
|---|---|---|---|
Return on Assets (Normalized) | 2.63% | −13.24% | 5.27% |
Return on Equity (Normalized) | 3.05% | −41.15% | 7.62% |
Return on Invested Capital (Normalized) | 2.51% | −23.76% | 6.69% |
Return on Assets
4547
4506
4577
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Tnwjwykwm | Pcqp | $86.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Tvlmlrxg | Hynqqh | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Lbwwgzql | Cntb | $46.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Jrmrjhgr | Xsmv | $19.9 Bil | |||
| Viatris Inc
VTRS
| Lgfhwtx | Mnxy | $13.6 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vlvbpcrt | Kvhj | $13.4 Bil | |||
| Catalent Inc
CTLT
| Hmxwnhck | Bysyyz | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Wvyqwwph | Hwbvc | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Srbyrns | Xcdnr | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rlzjhrcv | Hnwfd | $2.5 Bil |
United States